CTR076776 CONTRACT AMENDMENT NO.1.PDF

INTERGOVERNMENTAL AGREEMENT (IGA) 
 
Amendment  
ARIZONA DEPARTMENT OF 
HEALTH SERVICES 
OFFICE OF PROCUREMENT 
 
150 N. 18th Ave., Suite 530 
Phoenix, Arizona 85007 
Contract No.: CTR076776 
IGA Amendment No: 1 
Procurement Officer: 
Ryan Garcia 
 
 
Page 1 of 6 
Revised 05/29/2024 
 
 
STD CONTROL PROGRAM 
 
 
It is mutually agreed that the Intergovernmental Agreement referenced is amended as follows: 
 
1. Pursuant to Terms and Conditions, Provision Seven (7) Contract Changes, subsection 7.1 Amendments, the Contract 
is hereby revised with the following: 
 
1.1. The Scope of Work is revised and replaced to add price restrictions per test. 
 
ALL CHANGES ARE REFLECTED IN RED 
All other provisions of this agreement remain unchanged. 
Maricopa County Public Health 
 
 
Contractor Name:  
 
 
Authorized Signature 
4041 North Central Ave, Ste 1400 
 
 
 
Address:  
 
Print Name 
Phoenix 
AZ 
85012 
 
 
City 
State 
Zip 
 
Title and Date 
 
Pursuant to A.R.S. § 11-952, the undersigned public agency attorney has determined 
that this Intergovernmental Agreement is in proper form and is within the powers and 
authority granted under the laws of Arizona 
This Intergovernmental Agreement Amendment shall be 
effective the date indicated.  The Public Agency is hereby 
cautioned not to commence any billable work or provide any 
material, service or construction under this IGA until the IGA has 
been executed by an authorized ADHS signatory.  
 
State of Arizona 
 
Signature 
Date 
 
Signed this                          day  of                                  2026 
 
 
Print Name 
 
Procurement Officer 
 
 
Contract No.: CTR076776 Which is an Agreement between public agencies, has been 
reviewed pursuant to A.R.S. § 11-952 by the undersigned Assistant Attorney, who has 
determined that it is in proper form and is within the powers and authority granted 
under the laws of the State of Arizona. 
 
 
 
Signature 
Date 
 
Assistant Attorney General 
Print Name

INTERGOVERNMENTAL AGREEMENT (IGA) 
 
Amendment  
ARIZONA DEPARTMENT OF 
HEALTH SERVICES 
OFFICE OF PROCUREMENT 
 
150 N. 18th Ave., Suite 530 
Phoenix, Arizona 85007 
Contract No.: CTR076776 
IGA Amendment No: 1 
Procurement Officer: 
Ryan Garcia 
 
 
Page 2 of 6 
Revised 05/29/2024 
 
 
1. Background 
 
In Arizona in 2023, there were more than 41,000 chlamydia (CT) infections, more than 14,000 gonorrhea (GC) 
infections and more than 3,600 cases of syphilis. Since 2014, annual Sexually Transmitted Infection (STI) counts 
have increased by forty-seven percent (47%). This upward trend is projected to continue based on preliminary 
2024 data. The majority of reported chlamydia infections were in females between the ages of twenty (20) and 
twenty-four (24). The majority of reported gonorrhea infections were in males between the ages of twenty (20) and 
twenty-four (24). In women, untreated chlamydia and gonorrhea infections can spread into the uterus or fallopian 
tubes and cause pelvic inflammatory disease (PID), infertility, ectopic pregnancy, and chronic pelvic pain. Persons 
infected with syphilis may develop skin lesions and neurologic impairment. Syphilis can spread from the infected 
mother to their unborn child (congenital syphilis) causing stillbirth, low birth weight, congenital deformities, and/or 
prematurity. Persons infected with chlamydia, gonorrhea, or syphilis are more likely to become infected with HIV, 
if exposed. The majority of syphilis cases are in men, with the greatest percentage of these men being gay, bisexual 
and other men who have sex with men (GBMSM). 
 
To mitigate the spread of these infections and their tragic results, laboratory testing of high-risk populations is 
recommended. Arizona Department of Health Services (ADHS) maintains partnerships with the Maricopa County 
Department of Public Health (MCDPH), select community-based organizations and correctional facilities to 
facilitate the testing and treatment of chlamydia, gonorrhea, and syphilis in high risk populations. These efforts are 
in accordance with a cooperative agreement with the Centers for Disease Control and Prevention (CDC) through 
the Strengthening STD Prevention and Control for Health Departments (STD PCHD) grant. 
 
2. Objective 
 
To reduce the incidence and prevalence of STIs through the screening of high-risk populations, including GBMSM, 
and to increase the detection of rectal STIs through extragenital (pharyngeal and anorectal) screening by 
facilitating increased screening practices and test processing (including urine, vaginal, pharyngeal, rectal, and 
blood specimens) through the MCDPH Laboratory. 
 
3. Scope of Service 
 
The Contractor shall accept and process urine, vaginal, pharyngeal, and rectal specimens for nucleic acid 
amplification testing (NAAT) for CT and GC as well as specimens of blood for syphilis testing received from the 
sites agreed to by ADHS STI Control Program (STICP) and MCDPH which serve at-risk populations. 
 
4. Requirements 
 
The Contractor shall: 
 
4.1. 
Demonstrate enrollment and performance in a Clinical Laboratory Improvement Amendments (CLIA) 
approved proficiency testing program with copies of results of such testing provided to the ADHS STIC 
Program on an annual basis.

INTERGOVERNMENTAL AGREEMENT (IGA) 
 
Amendment  
ARIZONA DEPARTMENT OF 
HEALTH SERVICES 
OFFICE OF PROCUREMENT 
 
150 N. 18th Ave., Suite 530 
Phoenix, Arizona 85007 
Contract No.: CTR076776 
IGA Amendment No: 1 
Procurement Officer: 
Ryan Garcia 
 
 
Page 3 of 6 
Revised 05/29/2024 
 
 
4.2. 
Provide proof of appropriate laboratory certification and/or licensure to perform testing for Chlamydia 
trachomatis, Neisseria gonorrhea, Rapid Plasma Reagin (RPR) and syphilis antibody tests. 
 
4.3. 
Adhere to all lab reporting rules as listed here: https://www.adhs.gov/preparedness/epidemiology-disease-
control/index.php#reporting-labs. 
 
5. Funding Restrictions 
  
5.1. 
This contract will be federally funded by the CDC through the Strengthening STD Prevention & Control for 
Health Departments. 
 
Funds cannot be used for any of the following:  
 
5.1.2 
Research. 
 
5.1.3 
Furniture. 
 
5.1.4 
HIV Pre-exposure Prophylaxis (PrEP) medications or family planning medications. 
 
5.1.5 
Clinical services. 
 
5.1.6 
Supplies and services not outlined in this contract, including water and food supplies.  
 
6. Tasks 
 
The Contractor shall:  
 
6.1. 
Perform direct testing for the qualitative detection of both Chlamydia trachomatis and Neisseria gonorrhea 
(i.e. dual CT/GC laboratory testing) received from designated sites agreed to by STICP and MCDPH. 
 
6.2. 
Perform direct testing for qualitative and quantitative detection of RPR and Treponema pallidum antibodies 
received from designated sites approved by the ADHS STICP. 
 
6.3. 
Utilize test methodology according to procedures and protocols that comply with federal guidelines for the 
performance of laboratory screening tests for Nucleic Acid Amplification Tests (NAAT) for Chlamydia 
trachomatis, Neisseria gonorrhea, RPR, and Treponema pallidum according to manufacturer’s package 
insert guidelines. 
 
6.4. 
Provide CT, GC, and syphilis specimen collection supplies to the designated testing sites. 
 
6.5. 
Report all test results, both positive and negative, to submitting clinic sites within five (5) business days 
from the date of specimen receipt via currently acceptable reporting practices. 
 
6.6. 
Collaborate with the ADHS STICP to ensure uniformity in variable reporting and collect data elements as 
listed below:

INTERGOVERNMENTAL AGREEMENT (IGA) 
 
Amendment  
ARIZONA DEPARTMENT OF 
HEALTH SERVICES 
OFFICE OF PROCUREMENT 
 
150 N. 18th Ave., Suite 530 
Phoenix, Arizona 85007 
Contract No.: CTR076776 
IGA Amendment No: 1 
Procurement Officer: 
Ryan Garcia 
 
 
Page 4 of 6 
Revised 05/29/2024 
 
 
6.6.1 
    
 Lab Name. 
 
6.6.2 
            Accession Number. 
 
6.6.3 
            Accession Date. 
 
6.6.4 
            Specimen Source/Type. 
 
6.6.5 
            Clinic Code. 
 
6.6.6 
            Clinic Name. 
 
6.6.7 
             Patient First Name. 
 
6.6.8 
             Patient Last Name. 
 
6.6.9 
             Patient Sex. 
 
6.6.10              Patient Race. 
 
6.6.11              Patient Date of Birth. 
 
6.6.12              Patient Age. 
 
6.6.13              Patient Ethnicity. 
 
6.6.14              Date of Collection. 
 
6.6.15              Provider Name. 
 
6.6.16              Provider Address. 
 
6.6.17              Provider Zip Code. 
 
6.6.18              Provider Phone. 
 
6.6.19              Specimen Collection Date. 
 
6.6.20              Test Result. 
 
6.7. 
Report positive test results to ADHS STICP within five (5) business days from the date of specimen 
receipt according to AAC R9-6-204 Clinical Laboratory Director Reporting Requirements: 
https://azdhs.gov/documents/preparedness/epidemiology-disease-control/communicable-disease-
reporting/lab-reporting-requirments.pdf. 
 
6.8. 
Develop and maintain standard laboratory operating procedures and quality assurance protocols 
for the proposed test method(s). 
 
6.9. 
Maintain systems to ensure the confidentiality of information with patient identifiers. 
 
6.10. Distribute specimen collection kits and supplies to designated clinics on an as-needed basis.

INTERGOVERNMENTAL AGREEMENT (IGA) 
 
Amendment  
ARIZONA DEPARTMENT OF 
HEALTH SERVICES 
OFFICE OF PROCUREMENT 
 
150 N. 18th Ave., Suite 530 
Phoenix, Arizona 85007 
Contract No.: CTR076776 
IGA Amendment No: 1 
Procurement Officer: 
Ryan Garcia 
 
 
Page 5 of 6 
Revised 05/29/2024 
 
 
6.11. Provide transportation of specimens from clinic sites to laboratories for testing. 
 
6.12. Provide both positive and negative test results to submitting clinics within a five (5) day window period from 
the date of specimen receipt via currently acceptable reporting practices used by each site. 
 
6.13. Provide direct contact information for the point of contact and a back-up point of contact (key personnel) to 
ADHS to assist with the clarification of reports that contain missing or conflicting information. 
 
                           6.13.1    Report key personnel changes to ADHS STICP within five (5) business days.  
 
6.14. The contractor shall adhere to the billed rates as listed below and may not exceed these amounts without 
prior authorization. 
 
 
 
7. State-Provided Items 
 
ADHS will provide: 
 
7.1. Exhibit 1 - Required Data Elements. 
 
7.2. Exhibit 2 - Contractor Expenditure Report (CER). 
 
7.3. Exhibit 3 – CER Supporting Documentation Requirements. 
 
8. Approvals 
 
ADHS will require prior approval of: 
 
8.1. 
The ADHS STICP will approve the contractor’s service and work upon satisfactory completion and 
submission of all deliverables and reporting requirements. 
 
8.2. 
The Contractor shall obtain prior written approval from ADHS STICP for: 
 
8.2.1 
Contract amendment requests. 
 
Type of Unit 
Rate per Unit 
Unit of Measure 
Total Budget 
NAAT 
CT/GC 
Combination 
Test 
$12.30 
Each 
As specified on 
purchase order 
RPR Qualitative 
$3.29 
Each 
As specified on 
purchase order 
RPR 
Quantitative 
$6.90 
Each 
As specified on 
purchase order 
TPPA 
$5.51 
Each 
As specified on 
purchase order

INTERGOVERNMENTAL AGREEMENT (IGA) 
 
Amendment  
ARIZONA DEPARTMENT OF 
HEALTH SERVICES 
OFFICE OF PROCUREMENT 
 
150 N. 18th Ave., Suite 530 
Phoenix, Arizona 85007 
Contract No.: CTR076776 
IGA Amendment No: 1 
Procurement Officer: 
Ryan Garcia 
 
 
Page 6 of 6 
Revised 05/29/2024 
 
 
9. Deliverables 
 
The Contractor shall: 
 
9.1 
Provide positive test results to ADHS STICP within five (5) working days form the date of specimen receipt 
according 
to 
the 
AAC 
R9-6-204 
Clinical 
Laboratory 
Director 
Reporting 
Requirements: 
https://azdhs.gov/documents/preparedness/epidemiology-disease-control/communicable-disease-
reporting/lab-reporting-requirements.pdf. These reports are to be filed with ADHS via the current method of 
reporting to Maricopa County STD Control. 
 
9.2 
Provide monthly de-identified data submission for STI tests reimbursed through this project to include 
positive and negative results from the electronic laboratory information system in an Excel spreadsheet to 
the ADHS STICP. Such data submissions will be due on the tenth (10th) business day following the last day 
of the previous month.  
 
9.6  
Submit Contractor’s Expenditure Reports (CERs) thirty (30) days after the month end to the ADHS STICP 
as outlined in 10.1. 
 
10. Notices, Correspondence, Reports 
 
10.1 
Supporting documentation, and invoices/CERs from the Contractor to ADHS shall be sent to: 
 
Arizona Department of Health Services 
Attn: Meagan Surgenor STI Initiatives Manger 
Arizona Department of Health Services 150 N 18th Avenue, Suite 300 
Phoenix, AZ 85007-3242 
Email: Meagan.surgenor@azdhs.gov 
Phone: 480-407-9854 
10.2 
Correspondence from ADHS to the Contractor shall be sent to: 
 
Maricopa Department of Public Health  
Attn: Stephanie Delvin STI HIV and Lab Services Manager 
Maricopa Department of Public Health 4041 North Central Avenue, Suite 1400 
Phoenix, AZ 85012 
Email: Stephanie.Devlin@maricopa.gov 
Phone: 602-396-0965 
 
10.3 
ADHS may pay invoices for some or all Orders through an Automated Clearing House (ACH). In order to 
receive payments in this manner, the Contractor must complete an ACH Vendor Authorization Form (form 
GAO-618) within 30 (thirty) days after the effective date of the Contract. The form is available online at: 
https://gao.az.gov/publications/forms 
 
10.3.1   ACH Vendor Authorization Form shall be emailed to Vendor.Payautomation@azdoa.gov